These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 8664454

  • 1. Effects of a paf-receptor antagonist on hemodynamics during and after cardiopulmonary bypass.
    Nathan N, Mercury P, Denizot Y, Cornu E, Laskar M, Lathelize M, Arnoux B, Feiss P.
    J Cardiothorac Vasc Anesth; 1995 Dec; 9(6):647-52. PubMed ID: 8664454
    [Abstract] [Full Text] [Related]

  • 2. Effects of the platelet-activating factor receptor antagonist BN 52021 on hematologic variables and blood loss during and after cardiopulmonary bypass.
    Nathan N, Mercury P, Denizot Y, Cornu E, Laskar M, Arnoux B, Feiss P.
    Anesth Analg; 1994 Aug; 79(2):205-11. PubMed ID: 7639352
    [Abstract] [Full Text] [Related]

  • 3. Platelet-activating factor antagonist and cardiopulmonary bypass.
    Nathan N, Denizot Y.
    Ann Thorac Surg; 1995 Sep; 60(3):744-5. PubMed ID: 7677525
    [No Abstract] [Full Text] [Related]

  • 4. RETRACTED: Cardiorespiratory response of intravenous angiotensin-converting enzyme inhibitor enalaprilat in hypertensive cardiac surgery patients.
    Boldt J, Schindler E, Wollbrück M, Görlach G, Hempelmann G.
    J Cardiothorac Vasc Anesth; 1995 Feb; 9(1):44-49. PubMed ID: 7718754
    [Abstract] [Full Text] [Related]

  • 5. The clinical relevance of hemoglobin, platelet, and serotonin changes in sequestered and circulating blood during cardiopulmonary bypass.
    McNulty SE, Mannion J, Brennan M, Schieren H.
    J Cardiothorac Vasc Anesth; 1998 Aug; 12(4):402-7. PubMed ID: 9713727
    [Abstract] [Full Text] [Related]

  • 6. Hemodynamic effects of milrinone during weaning from cardiopulmonary bypass: comparison of patients with a low and high prebypass cardiac index.
    Yamada T, Takeda J, Katori N, Tsuzaki K, Ochiai R.
    J Cardiothorac Vasc Anesth; 2000 Aug; 14(4):367-73. PubMed ID: 10972598
    [Abstract] [Full Text] [Related]

  • 7. Clonidine improves perioperative myocardial ischemia, reduces anesthetic requirement, and alters hemodynamic parameters in patients undergoing coronary artery bypass surgery.
    Dorman BH, Zucker JR, Verrier ED, Gartman DM, Slachman FN.
    J Cardiothorac Vasc Anesth; 1993 Aug; 7(4):386-95. PubMed ID: 8400091
    [Abstract] [Full Text] [Related]

  • 8. Desmopressin acetate is a mild vasodilator that does not reduce blood loss in uncomplicated cardiac surgical procedures.
    Reich DL, Hammerschlag BC, Rand JH, Weiss-Bloom L, Perucho H, Galla J, Thys DM.
    J Cardiothorac Vasc Anesth; 1991 Apr; 5(2):142-5. PubMed ID: 1863725
    [Abstract] [Full Text] [Related]

  • 9. A bolus dose of 1.5 mg/kg amrinone effectively improves low cardiac output state following separation from cardiopulmonary bypass in cardiac surgical patients.
    Kikura M, Levy JH, Bailey JM, Shanewise JS, Michelsen LG, Sadel SM.
    Acta Anaesthesiol Scand; 1998 Aug; 42(7):825-33. PubMed ID: 9698960
    [Abstract] [Full Text] [Related]

  • 10. Platelet-activating factor (PAF)-induced cardiopulmonary dysfunctions and their reversal with a PAF antagonist (BN 52021) in strain 13 guinea pigs.
    Qian C, Guo ZM, Peters CJ, Liu CT.
    J Lipid Mediat; 1993 Jul; 7(3):223-37. PubMed ID: 8219003
    [Abstract] [Full Text] [Related]

  • 11. The importance of aprotinin and pentoxifylline in preventing leukocyte sequestration and lung injury caused by protamine at the end of cardiopulmonary bypass surgery.
    Ege T, Arar C, Canbaz S, Cikirikcioglu M, Sunar H, Yuksel V, Duran E.
    Thorac Cardiovasc Surg; 2004 Feb; 52(1):10-5. PubMed ID: 15002070
    [Abstract] [Full Text] [Related]

  • 12. Role of platelet-activating factor in leukocyte-independent plasma extravasation and mast cell activation during endotoxemia.
    Walther A, Yilmaz N, Schmidt W, Bach A, Gebhard MM, Martin E, Schmidt H.
    J Surg Res; 2000 Oct; 93(2):265-71. PubMed ID: 11027469
    [Abstract] [Full Text] [Related]

  • 13. Variations in blood platelet-activating-factor levels after protamine reversal of heparin in humans.
    Nathan N, Denizot Y, Feiss P, Cornu E, Benveniste J, Arnoux B.
    Acta Anaesthesiol Scand; 1992 Apr; 36(3):264-9. PubMed ID: 1574976
    [Abstract] [Full Text] [Related]

  • 14. Short-term and long-term role of platelet activating factor as a mediator of in vivo platelet aggregation.
    Golino P, Ambrosio G, Ragni M, Pascucci I, Triggiani M, Oriente A, McNatt J, Buja LM, Condorelli M, Chiariello M.
    Circulation; 1993 Sep; 88(3):1205-14. PubMed ID: 8353882
    [Abstract] [Full Text] [Related]

  • 15. Effect of a platelet-activating factor (PAF) receptor antagonist on hyperacute xenograft rejection; evaluation in a pig kidney-human blood xenoperfusion model.
    Cruzado JM, Torras J, Riera M, Lloberas N, Herrero I, Condom E, Martorell J, Alsina J, Grinyó JM.
    Clin Exp Immunol; 1998 Jul; 113(1):136-44. PubMed ID: 9697996
    [Abstract] [Full Text] [Related]

  • 16. Hemodynamic effects of PAF-acether on the dog kidney.
    Hébert RL, Sirois P, Braquet P, Plante GE.
    Prostaglandins Leukot Med; 1987 Mar; 26(3):189-202. PubMed ID: 3033688
    [Abstract] [Full Text] [Related]

  • 17. Effects of PAF and BN 52021 on cardiac function and regional blood flow in conscious rats.
    Sirén AL, Feuerstein G.
    Am J Physiol; 1989 Jul; 257(1 Pt 2):H25-32. PubMed ID: 2546449
    [Abstract] [Full Text] [Related]

  • 18. Role of platelet-activating factor in the ovine heparin-protamine reaction.
    Montalescot G, Huerta JM, Braquet P, Zapol WM.
    J Appl Physiol (1985); 1992 Dec; 73(6):2604-7. PubMed ID: 1490976
    [Abstract] [Full Text] [Related]

  • 19. Impact of PAF antagonist BN 52021 (Ginkolide B) on post-ischemic graft function in clinical lung transplantation.
    Wittwer T, Grote M, Oppelt P, Franke U, Schaefers HJ, Wahlers T.
    J Heart Lung Transplant; 2001 Mar; 20(3):358-63. PubMed ID: 11257563
    [Abstract] [Full Text] [Related]

  • 20. Amino acid-enriched glucose-insulin-potassium infusion improves hemodynamic function after coronary bypass surgery. A double-blind study in patients with unstable angina and/or compromised left ventricular function.
    Wistbacka JO, Lepojärvi MV, Karlqvist KE, Koistinen J, Kaukoranta PK, Nissinen J, Peltola T, Rainio P, Ruokonen A, Nuutinen LS.
    Infusionsther Transfusionsmed; 1995 Apr; 22(2):82-90. PubMed ID: 7787408
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.